AUTHOR=Martinez-Vaz Betsy M. , Dodge Anthony G. , Lucero Rachael M. , Stockbridge Randy B. , Robinson Ashley A. , Tassoulas Lambros J. , Wackett Lawrence P. TITLE=Wastewater bacteria remediating the pharmaceutical metformin: Genomes, plasmids and products JOURNAL=Frontiers in Bioengineering and Biotechnology VOLUME=10 YEAR=2022 URL=https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.1086261 DOI=10.3389/fbioe.2022.1086261 ISSN=2296-4185 ABSTRACT=
Metformin is used globally to treat type II diabetes, has demonstrated anti-ageing and COVID mitigation effects and is a major anthropogenic pollutant to be bioremediated by wastewater treatment plants (WWTPs). Metformin is not adsorbed well by activated carbon and toxic N-chloro derivatives can form in chlorinated water. Most earlier studies on metformin biodegradation have used wastewater consortia and details of the genomes, relevant genes, metabolic products, and potential for horizontal gene transfer are lacking. Here, two metformin-biodegrading bacteria from a WWTP were isolated and their biodegradation characterized.